Skip to Content

Texas Oncology offering ‘GREAT’ program for breast cancer

Denim Ervin highlights early detection and genetic testing as key tools for understanding and reducing breast cancer risk.
Cancer Prevention

The Paris News

October 7, 2024

When it comes to breast cancer, good news is always welcome. Texas Oncology–Paris has some good news — in fact, it has great news. “At Paris Texas Oncology, we are part of a service called the genetic risk evaluation and testing (GREAT) program which provides testing for cancer associated hereditary gene mutations,” said Denim Ervin, RN, APN, MNSc, who is a nurse practitioner at Texas Oncology in Paris. The program consists of advanced practice providers who are trained in the methodology of genetic screening, she said.

But, if that isn’t enough, they are backed up and overseen by genetic counselors across Texas Oncology, she said. People who have a personal history of breast cancer or know that it has run in their family are prime candidates for genetic testing, she noted.

“It is a good idea for anybody who has a family history of cancer, but anyone can be tested,” she said.

Those who get involved in the GREAT program will get an evaluation of their risk for developing cancer. That evaluation will include a review of family history, medical history, lifestyle risk factors, and age.

“A GREAT visit will help us determine if testing is recommended, if an individual meets criteria for testing, and if it will be covered by insurance,” she said.

Those that do go through the process will have a blood test after the evaluation.

“The presence of a breast cancer associated genetic mutation can significantly alter the recommendation for surveillance for breast cancer, including earlier, more frequent or additional screening such as MRI,” she said. “Certain gene mutations can even come with a recommendation to consider risk reducing surgery or medications to reduce the risk of developing breast cancer.”

She added that for women who have a diagnosis of breast cancer, the presence of a gene mutation can influence surgical recommendations, and sometimes treatment options.

When it comes to breast cancer, or any other cancer, earlier detection is a key.

Ervin offered some facts about breast cancer:

  1. Breast cancer is the second-deadliest cancer among American women. In addition to adopting a healthy lifestyle, early detection with regular mammograms remains the most effective way to combat the disease. Steady declines in breast cancer deaths among women since 1989 have been attributed to a combination of early detection and improvements in treatment.

  2. In Texas in 2024, an estimated 23,290 new cases of breast cancer are expected, with 3,208 deaths.

  3. Breast cancer cannot be completely prevented, but women can take steps to decrease risk and/or improve early detection of the disease. Screening recommendations are for women with average risk. It is important to discuss with a physician your individual risk factors, including age, menopausal status, and family history to determine your screening needs.

  4. Women should understand their individual risk, as some women with a family history of breast cancer or certain other risk factors should start routine breast cancer screenings early and take other preventive measures before age 40.

  5. Women should check their breasts monthly and report any changes to a physician immediately.

  6. Women in their 20s and 30s should have a clinical breast exam every three years.

  7. Women in their 30s should discuss their individual breast cancer risk level with a physician to determine the most appropriate cancer screening options, including mammograms and MRI screenings.

  8. Women 40 and older should have a mammogram once a year. Women should discuss individual risk factors with a physician to determine recommended additional screenings including annual ultrasounds and MRI screenings to drive early detection.

Individuals who are interested in genetic evaluation can start with an appointment for a GREAT visit to determine if testing is recommended. For more information on screening go to TexasOncology.com/services-and-treatments/genetic-testing.

This article was originally published in The Paris News.